Live
- Manchester United Secure 2-0 Europa League Win Over PAOK Thanks to Amad Diallo's Brace
- Mother-daughter duo killed over property dispute
- CERT-In Urges iPhone Users to Update to iOS 18.1 to Avoid Security Risks
- Ashutosh Rana Reflects on Life, Career, and Changing Landscape of Cinema
- Backyard poultry farming to extend to all districts
- E-way bills for goods soar to record high as trade surges in Oct
- IDCO official arrested on graft charge
- 'Maha always maintained communal harmony': Ajit Pawar on 'Batenge to Katenge' call
- Indian Rupee Hits Historic Low of 84.37 Against US Dollar Amid Global Economic Shifts
- Man held for posting obscene photos
Microsoft launching 'plasmabot' to urge recovered patients donate plasma
As countries including India explore plasma therapy to treat severe COVID-19 patients, Microsoft is launching a plasmabot initiative to encourage people who have been recovered from the deadly disease donate their plasma.
San Francisco:As countries including India explore plasma therapy to treat severe COVID-19 patients, Microsoft is launching a plasmabot initiative to encourage people who have been recovered from the deadly disease donate their plasma.
Several studies have begun in different parts of the world to test effectiveness of convalescent plasma therapy in treating COVID-19 patients. The idea behind this therapy is that immunity can be transferred from a healthy person to a sick using convalescent plasma.
Convalescent plasma refers to plasma from recovered COVID-19 patients.
According to a CNBC report, Microsoft is working with a consortium of pharmaceutical companies to launch a "plasmabot" this weekend to reach out to people who wish to donate their plasma .
"The plasmabot will also provide information about the procedure and direct them to a nearby site where they can safely make the donation," said the report.
In this therapy, blood is drawn from a person who has recovered from the disease and the serum is separated and screened for virus-neutralising antibodies.
When attacked by a pathogen, our immune systems produce antibodies and in this therapy, these antibodies from recovered patients are used to treat other sick people.
According to Microsoft's head of research Peter Lee, "the goal is to recruit as much plasma as soon as possible".
Mirosoft is supporting the efforts of plasma alliance formed by companies like Octapharma, Takeda, CSL Behring and others.
Lee said he believes the plasma therapy has the "potential to save lives."
According to Neha Gupta, Infectious Diseases Consultant at Fortis Memorial Research Institute in Gurugram, immunity develops early in asymptomatic or persons with mild symptoms, while it develops later in severe and critically-ill COVID 19 patients.
The process for donating plasma is similar to donating blood and takes about an hour, according to Houston Methodist which became the first academic medical centre in the US to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient.
Plasma donors are hooked up to a small device that removes plasma while simultaneously returning red blood cells to their bodies. Unlike regular blood donation in which donors have to wait for red blood cells to replenish between donations, plasma can be donated more frequently, as often as twice a week, it said.
In India, states like Kerala and Gujarat have started Convalescent Plasma Therapy from to treat Covid-19 patients.
